NETCast: Recent Episodes
Podcasting4Associations
NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).
Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.
Visit us at
https://nanets.net/
In this episode of NETCast, which was taped live during NANETS' Cleveland NET Regional Educational Conference, leading NET medical experts held a discussion of Hormonal Management of NETs: Syndromes and Symptom Control, moderated by Amr Mohamed, MD, UH Seidman Cancer Center, University Hospital, and guests Lauren Fishbein, MD, PhD, University of Colorado, and Thorvardur Halfdanarson, MD, Mayo Clinic. Dr. Mohamed, who also served as Course Director for the NET Regional, is a medical oncologist at UH Hospitals Seidman Cancer Center, focusing on development of targeted therapies for patients with GI cancers, especially neuroendocrine tumors and colorectal cancer. Dr. Fishbein's research interests are to understand what causes neuroendocrine tumors to form (pheochromocytomas, paragangliomas, gastrointestinal and pancreatic neuroendocrine tumors). She is particularly interested in studying the inherited and tumor specific genetic changes that lead to tumor formation. Dr. Halfdanarson specializes in GI oncology. He is the program director for the Hematology/Oncology Fellowship Program at Mayo Clinic and is the current VP of the North American Neuroendocrine Tumor Society.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Tune in to hear our first taping of NETCast from Canada, recorded live during the NET Regional educational conference in Toronto. Our moderators are Dr. Julie Hallet and Dr. Simron Singh. Dr. Hallet is Associate Scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Assistant Professor, Dept. of Surgery, University of Toronto Surgical Oncologist, Sunnybrook Health Sciences Centre, Adjunct Scientist, Institute of Evaluative Clinical Sciences (ICES). As a surgeon investigator, her research focuses on health services population based research to examine processes, patterns of care, and outcomes of hepato-pancreato-biliary malignancies. In particular.
Dr. Singh is a Medical Oncologist and Affiliate Scientist in the Odette Cancer Research Program at Sunnybrook Research Institute. He is also Assistant Professor at the University of Toronto. Dr. Singh's research interests include neuroendocrine carcinomas as well as population health and cancer care utilization discrepancies. He is co-head of a newly established multi-disciplinary specialized neuroendocrine clinic at Sunnybrook’s Odette Cancer Center, one of the first in the region. He is involved in numerous activities in the care of neuroendocrine cancer including the role of ki-67 as a prognostic marker, and the utilization of health care resources in the diagnosis and treatment of neuroendocrine tumour patients.
Our guests are Dr. Callisia Clarke and Dr. Sten Myreheug. Dr. Clarke is Associate Professor, Medical College of Wisconsin. She specializes in Surgical Oncology with a focus on tumors of the upper gastrointestinal tract, sarcomas, melanomas and regional therapies for advanced malignancies. Her research interests are centered on personalized cancer care and targeted approaches in Pancreatic Neuroendocrine Tumors.
Dr. Myreheug is Assistant Professor, Radiation Oncology, at Odette Cancer Centre, Sunnybrook Health Sciences Centre. He specializes in central nervous system malignancies, gastrointestinal and neuroendocrine malignancies. We ae thrilled to add this important conversation to our NETCast series.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Tune in for this live discussion recorded from NANETS annual conference and moderated by Dr. Jason Starr, Mayo Clinic, and featuring guests Dr. Jennifer Eads, Penn Medicine, and Dr. Aman Chauhan, University of Kentucky Markey Cancer Center.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Tune in for a lively debate on when, when not to, and if one should operate, with Diane Reidy-Lagunes, MD, Vice Chair of Oncology Operations, Regional Cancer Network; Past President, MSK Medical Staff; Creator and Host, Cancer Straight Talk Podcast, and past NANETS board member; and James Howe, MD, Professor of Surgery, Co-Director, Neuroendocrine Cancer Clinic, Director of Surgical Oncology and Endocrine Surgery, University of Iowa Carver College of Medicine, and past NANETS President; with guest moderator, Alexandra Gangi, MD, Associate Program Director, Complex General Surgical Oncology Program, Director Gastrointestinal Tumor Program, Cedars Sinai, and Chair, NANETS Communications Committee.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Tune in to listen as leading NET medical experts from different areas of specialization discuss and debate key factors that are critical in diagnosing and treating NET patients.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).
Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.